SeeNext Venture · Recalled
NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
- Units
- About 8,000
- Reports
- —
- Injuries
- —
- Deaths
- 0
- Price
- $25
- Remedy
- Replace
Reports, injuries, deaths and price are read out of the notice’s wording by rules, so they can miss unusual phrasing. The official notice is the record.
Affected
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.
The file
- Sold at
- Online at Amazon.com from October 2019 through February 2020 for about $25.
- Product type
- Not stated
- Made in
- Canada
- Recalled by
- SeeNext Venture Ltd., of Blaine, Wash.
Incident log
None reported.
What the notice says to do
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly.
SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at distributions@numbskin.com or online at www.numbskin.com and click on Recall at the home page for more information.
Recall notice published by the U.S. Consumer Product Safety Commission. This site is independent: always confirm on the official notice before acting.